News | Sofia Fund Investments

Sofia Fund Invests in Kenzen

September 5, 2018 (Minneapolis) – Sofia Fund, a leading angel investment group focused on high-growth, women-led early stage companies, today announced its most recent investment in Kenzen, a San Francisco-based health analytics platform focused on predicting and preventing avoidable health conditions. Kenzen is the maker of Kenzen Patch™, a wearable vital sign and sweat-analysis system that continuously monitors parameters needed to detect heat-related injuries in workers and at-risk...

Sofia Fund Invests in Joylux, Inc

SOFIA FUND ANNOUNCES INVESTMENT IN HEALTH TECHNOLOGY COMPANY JOYLUX   MAY 3, 2018 (Minneapolis) — Sofia Fund, a leading angel investment firm focused on high-growth, women-led early stage companies, today announced it has invested in Joylux, Inc., the Seattle-based women’s intimate health and wellness company. The Sofia Fund investment was part of Joylux’s recent Series A financing round, which closes...

Sofia Fund Makes Third Investment in Cognition Therapeutics

Sofia Fund recently announced its third investment in Cognition Therapeutics, Inc. (CogRx), a Pittsburgh-based biopharmaceutical company that discovers, develops and manufactures innovative therapeutics for the treatment of Alzheimer’s disease and other neurocognitive disorders. The Sofia Fund investment was part of Cognition Therapeutic’s most recent financing round, through which the company hopes to raise up to $5...